Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
new york top stories
5
×
boston blog main
boston top stories
new york blog main
fda
san francisco top stories
drugs
national
new york
roche
san diego blog main
san diego top stories
san francisco blog main
abbvie
acorda therapeutics
allergan
allopregnanolone
ampyra
apokyn
apomorphine
billy dunn
biogen
biotech
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
bristol-myers squibb
cancer
clinical data
companion diagnostic
dalfampridine
detroit blog main
detroit top stories
dna sequencing
What
approved
5
×
drug
new
5
×
fda
medicine
disease
friday
oks
patients
acorda
atrophy
brexanolone
cancer
cope
daily
data
deeper
depression
devastating
disorder
dna
episodes
evrysdi
fast
fatty
fingerprint
genetic
gets
going
green
help
home
horizon
intended
intercept
known
late
lights
liquid
liver
Language
unset
Current search:
approved
×
new
×
" new york top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues